Related Experiment Videos
Risk of anomalies as a function of level of elevated maternal serum alpha-fetoprotein
A Reichler1, R F Hume, A Drugan
1Department of Obstetrics and Gynecology, Hutzel Hospital/Wayne State University, Detroit, MI 48201.
Objective:
Most neural tube defects risks are not actual but mathematical extrapolations. We sought to evaluate this risk and to compare actual performance.
Study Design:
This was a retrospective study of a referral population with elevated maternal serum alpha-fetoprotein results between 1987 and 1992. Ultrasonography results, delivery records, and autopsy results were compared with entry levels of maternal serum alpha-fetoprotein, and the percentage of fetal anomalies detected in this study was evaluated.
Results:
A total of 773 patients with elevated maternal serum alpha-fetoprotein levels were evaluated. There was a progressive increase in the incidence of anomalies as a direct function of the level of the maternal serum AFP, varying from 3.4% at a level of 2.5 to 40.3% at a level > 7.0.
Conclusion:
Data from this study support the correlation of maternal serum AFP levels with the risk of neural tube defect and ventral wall defects.